The Patent (Amendment) Law Number 14 of 2001 became effective from August 1 this year. However, the implementing regulations have not yet been issued by the government. The major changes under the new Patent Law involve perfection, addition and elimination.
An invention is deemed to be novel if on the filing date the invention is not the same as the prior art. What is meant by prior art is technology which has been published in Indonesia or outside Indonesia, in a written form, verbal description, or by a demonstration of its use, or in any other way that would enable a specialist to implement said invention before the filing date or priority date. The aforesaid prior art includes documents of patent applications filed in Indonesia which are published on or after the filing date on which their substantive examinations are being processed, but said filing date is earlier than the filing date or the priority date of application.
Simple patents
Any invention being a product or equipment which is novel and having practical value because of its shape, configuration, construction or components, may be granted legal protection in the form of a simple patent. A publication period is also valid for a simple patent, and it will be carried out three months at the latest from the filing date. The legal protection for a simple patent now begins from the filing date to provide opportunities for the simple patent holder to file a claim for indemnification against infringements which might have taken place after the filing date. Claims for remedy may be filed after the granting of a simple patent. The substantive examination period is 24 months from the filing date.
A patent shall not be granted to the following inventions:
A process or product of which the announcement and use or implementation contravenes the prevailing regulations, religious code, public order, or morality.
Methods of examination, treatment, medication, and/or surgery applied to people and/or animals, if such examination, treatment, medication and/or surgery shall involve the use of medical equipment. This provision is applied only for the method of invention. Others, such as medical equipment including the means, components or medicine shall be exempt from this provision.
A theory and method in the field of science and mathematics.
All living beings, except microorganisms.
Essential biological processes to reproduce plants or animals, except non-biological processes or micro-biological processes.
Quick end to disputes
As patenting is very closely associated with economic and trade activities, all civil cases involving patents must be quickly adjudicated, and therefore, civil cases should be adjudicated at the Commercial Court and not the District Court.
The Directorate General of Intellectual Property has been authorized to issue compulsory licences. This is intended to simplify the procedures and improve services to the public.
A temporary injunction is provided as the first effort to prevent further damage to the party whose right has been infringed. Therefore, the Commercial Court, at the request of the applicant, is authorized to produce immediate and effective judgment, so as to prevent further infringement, the continued supply of goods suspected to involve patent infringements into the markets, as well as the importation thereof.
However, as an alternative, disputes can be settled through an arbitration body or by way of other methods of alternative dispute resolution such as negotiation, mediation, conciliation, or other means selected by the relevant parties concerned, in accordance with the prevailing laws.
Parallel importation legal
The scope of the acts which would constitute an infringement under the new Patent Law has also been restricted. The new Patent Law provides that parallel importation of patented products will not amount to an infringement. This is presumably aimed at enhancing competition by enabling consumers to obtain genuine patented products at more competitive prices. Similarly, the use of a pharmaceutical patent in Indonesia within a period of two years before the expiry of the patent protection will also not amount to an infringement if such use is for the purpose of obtaining approval and thereupon conduct marketing upon the expiry of the patent protection. This exemption is to ensure the supply of pharmaceutical products by other parties after the patent protection has expired. In this way, prices can be maintained at reasonable levels.
Patent applications filed before the enactment of this new Patent Law, will be processed according to Law Number 6 of 1989 concerning patent as amended by Law Number 13 of 1997 concerning the Amendment on Law Number 6 of 1989 concerning patent.
© Cita Citrawinda Priapantja 2001. The author is an IPR consultant with Biro Oktroi Roosseno in Jakarta